Otsuka (OTCMKTS:OTSKY) Shares Up 10.6% – Time to Buy?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s stock price traded up 10.6% during mid-day trading on Tuesday . The company traded as high as $38.20 and last traded at $38.05. Approximately 589 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 40,075 shares. The stock had previously closed at $34.4080.

Otsuka Stock Up 4.5%

The firm has a 50-day moving average of $34.14 and a 200 day moving average of $33.60. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. The stock has a market capitalization of $40.77 billion, a price-to-earnings ratio of 15.24, a PEG ratio of 7.60 and a beta of -0.04.

Otsuka (OTCMKTS:OTSKY) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.The firm had revenue of $4.41 billion during the quarter, compared to the consensus estimate of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. As a group, sell-side analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 1.96 earnings per share for the current fiscal year.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.